These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31466437)

  • 1. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy.
    Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H
    Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resonance Energy Transfer-Promoted Photothermal and Photodynamic Performance of Gold-Copper Sulfide Yolk-Shell Nanoparticles for Chemophototherapy of Cancer.
    Chang Y; Cheng Y; Feng Y; Jian H; Wang L; Ma X; Li X; Zhang H
    Nano Lett; 2018 Feb; 18(2):886-897. PubMed ID: 29323915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
    Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
    Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
    Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
    Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.
    Su Z; Chen M; Xiao Y; Sun M; Zong L; Asghar S; Dong M; Li H; Ping Q; Zhang C
    J Control Release; 2014 Dec; 196():370-83. PubMed ID: 25278256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
    Li B; Xu H; Li Z; Yao M; Xie M; Shen H; Shen S; Wang X; Jin Y
    Int J Nanomedicine; 2012; 7():187-97. PubMed ID: 22275834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
    Zhong XC; Shi MH; Liu HN; Chen JJ; Wang TT; Lin MT; Zhang ZT; Zhou Y; Lu YY; Xu WH; Gao JQ; Xu DH; Han M; Chen YD
    Pharm Dev Technol; 2021 Jan; 26(1):21-29. PubMed ID: 33070673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.
    Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y
    J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO
    Li S; Song X; Zhu W; Chen Y; Zhu R; Wang L; Chen X; Song J; Yang H
    ACS Appl Mater Interfaces; 2020 Jul; 12(27):30066-30076. PubMed ID: 32393026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
    Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
    J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.